Blood component concentration measurement device

US12533057B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12533057-B2
Application numberUS-202017771725-A
CountryUS
Kind codeB2
Filing dateNov 5, 2020
Priority dateNov 8, 2019
Publication dateJan 27, 2026
Grant dateJan 27, 2026

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention is provided with a four-wavelength light emitter that emits four kinds of wavelengths of light toward a predetermined site on a living body; a light receiver that receives the four kinds of wavelengths of light transmitted through the predetermined site on the living body; a received light intensity information acquirer that acquires received light intensity information for the four wavelengths on the basis of an optical signal received by the light receiver; an absorbance time change value acquirer that finds time change values of the absorbances corresponding to the four wavelengths on the basis of the received light intensity information of the four wavelengths; a calibration data table that stores calibration data for finding a predetermined component in blood based on the absorbance time change values; and a component concentration acquirer that finds the concentration of the predetermined component in the blood.

First claim

Opening claim text (preview).

The invention claimed is: 1 . A blood component concentration measurement device comprising: four LEDs that are configured to be driven, in order, for a predetermined time, wherein each of the four LEDs is configured to emit a different wavelength of light toward a predetermined site on a living body; a light receiver that is configured to receive light that is emitted from each of the four LEDs and transmitted though the predetermined site on the living body, a data input interface that receives an output from the light receiver corresponding to the different wavelength of light emitted by each of the four LEDs, wherein the data input interface obtains light data on the different wavelength of light emitted by each of the four LEDs and performs A/D conversion to convert the light data into light intensity information; a central processing unit; and a non-transitory computer-readable recording medium that stores executable instructions that define an absorbance time change value acquirer and that define a component concentration acquirer, the executable instructions that define the absorbance time change value acquirer cause the central processing unit to compute an intermediate parameter using the following equation: ( p ⁢ A p ⁢ B p ⁢ C p ⁢ D ) = ( a 1 b 1 c 1 d 1 a 2 b 2 c 2 d 2 a 3 b 3 c 3 d 3 a 4 b 4 c 4 d 4 ) ⁢ ( ω λ 1 ω λ 2 ω λ 3 ω λ 4 )

Assignees

Inventors

Classifications

  • A61B5/1455Primary

    using optical sensors, e.g. spectral photometrical oximeters · CPC title

  • for analysing liquids, e.g. polluted water · CPC title

  • for measuring glucose, e.g. by tissue impedance measurement · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12533057B2 cover?
The present invention is provided with a four-wavelength light emitter that emits four kinds of wavelengths of light toward a predetermined site on a living body; a light receiver that receives the four kinds of wavelengths of light transmitted through the predetermined site on the living body; a received light intensity information acquirer that acquires received light intensity information fo…
Who is the assignee on this patent?
Aist, Cbc Co Ltd
What technology area does this patent fall under?
Primary CPC classification A61B5/1455. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jan 27 2026 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).